Publications by authors named "Gini Fleming"

Claim this Profile
R
Retrospective evaluation of adjuvant capecitabine dosing patterns in triple negative breast cancer.
Kun Lin, Elena Michaels, Eric Polley, Peter H O'Donnell, Frederick M Howard, Gini F Fleming

J Oncol Pharm Pract· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of gynecologic malignancy with trastuzumab deruxtecan in three patients with mutations.
Divya S Choudhury, Katherine C Kurnit, S Diane Yamada, Nita K Lee, Anusha Vemuri, Gini F Fleming

Gynecol Oncol Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Deeper Dive into POLE-Mutated Endometrial Carcinomas: The Contributions and Consequences of Tumor Mutational Burden.
Anusha Vemuri, Melissa Y Tjota, Pankhuri Wanjari, Gini F Fleming, Peng Wang

Am J Surg Pathol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index.
Ruth M O'Regan, Yue Ren, Yi Zhang, Natalia Siuliukina, Catherine A Schnabel, Gini F Fleming

JAMA Netw Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboplatin, gemcitabine, and mifepristone for advanced breast and recurrent/persistent epithelial ovarian cancer.
Erica M Stringer-Reasor, Poornima Saha, Masha Kocherginsky, Ricardo Lastra, Gabrielle Baker, Gini F Fleming

Breast Cancer Res Treat· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Race and neighborhood disadvantage in patients with stage I-III endometrioid endometrial carcinoma treated at a tertiary referral center.
Sarah A Ackroyd, Gabrielle Sudilovsky, Yan Che, Austin Wesevich, Sandra Tilmon, Gini F Fleming

Gynecol Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of racial differences in HER2 status and molecular subtype in grade 3 endometroid endometrial carcinoma.
Sarah A Ackroyd, Gabrielle Sudilovsky, Yan Che, Jennifer A Bennett, S Diane Yamada, Gini F Fleming

Gynecol Oncol Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of patient-reported depression in women with hormone-responsive early breast cancer in TEXT and SOFT.
Karin Ribi, Bernard F Cole, Gini F Fleming, Barbara A Walley, Prudence A Francis

Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2, two-stage study of avelumab and axitinib in patients with mismatch repair proficient recurrent or persistent endometrial cancer.
Elizabeth K Lee, Niya Xiong, Carolyn Krasner, Madeline Polak, Susana Campos, Gini F Fleming

Gynecol Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early-Phase Trials in .
Thomas E Stinchcombe, Gini F Fleming, Charles Craddock, Andrew H Ko, Eileen M O'Reilly

J Clin Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Veliparib concomitant with first-line chemotherapy and as maintenance therapy in ovarian cancer: Final overall survival and disease-related symptoms results.
Robert L Coleman, Gini F Fleming, Mark F Brady, Elizabeth M Swisher, Karina D Steffensen

Eur J Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Reflections on the HORSE Trial: Hyperthermic Intraperitoneal Chemotherapy, Status, and Clinical Implications.
Gini F Fleming

J Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Changes in Stress and Isolation Among Multi-Ethnic Breast Cancer Survivors Throughout COVID-19.
Fangyuan Zhao, Jincong Q Freeman, Nora Jaskowiak, Gini F Fleming, Rita Nanda

Stress Health· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer.
Nan Chen, Margarite Matossian, Poornima Saha, Murtuza Rampurwala, Salaija Kamaraju, Gini F Fleming

Breast Cancer Res Treat· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in uterine serous carcinoma and uterine carcinosarcoma.
Gini Fleming

Clin Adv Hematol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin for patients with advanced stage ovarian cancer: A randomized phase II placebo-controlled trial.
Iris L Romero, Ernst Lengyel, Andrea E Wahner Hendrickson, Gustavo C Rodriguez, Charles A Leath, Gini F Fleming

Gynecol Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of selective glucocorticoid receptor modulation in high-grade serous ovarian cancer PDX models.
Manisha Taya, Xiaonan Hou, Jennifer T Veneris, Nina Kazi, Melissa C Larson, Gini F Fleming

J Gynecol Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical Trials.
Stephen J Luen, Lauren C Brown, Courtney T van Geelen, Peter Savas, Roswitha Kammler, Gini F Fleming

JCO Precis Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining Response and Toxicity Data to Implement Project Optimus.
Robert G Maki, Thomas E Stinchcombe, Gary K Schwartz, Gini F Fleming, Alexia E Iasonos

J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of cyclin-dependent kinase 4/6 inhibitor-induced serum creatinine elevations in patients with hormone receptor positive breast cancer.
Emily Ly, Frederick M Howard, Nan Chen, Olwen Hahn, Gini F Fleming

J Oncol Pharm Pract· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor-Positive Breast Cancer.
Ruth M O'Regan, Yi Zhang, Gini F Fleming, Prudence A Francis, Roswitha Kammler

JAMA Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the RSClin risk calculator in the National Cancer Data Base.
Augustin G L Vannier, Asim Dhungana, Fangyuan Zhao, Nan Chen, Sarah Shubeck, Gini F Fleming

Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials.
Zachary A Kopelman, Chunqiao Tian, Jordyn Tumas, Neil T Phippen, Christopher M Tarney, Gini F Fleming

Gynecol Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flashback Foreword: Concurrent Chemotherapy/Radiotherapy for Cervical Cancer.
Gini F Fleming

J Clin Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase IIa Study of PLX2853 in Gynecologic Cancers With Known ARID1A Mutation and Phase Ib/IIa Study of PLX2853/Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer.
Linda R Duska, Dmitriy Zamarin, Erica Hamilton, Amit Oza, Gini Fleming

JCO Precis Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis